Bacterial antigen expression is an important component in inducing an immune response to orally administered salmonella-delivered DNA vaccines

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Gahan, Michelle E ^a,b,c,e   Webster, Diane E ^b,d   Wesselingh, Steven L ^b,c   Strugnell, Richard A ^a   Yang, Ji ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VECTOR; DNA VACCINE; IMMUNOGLOBULIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BETA GALACTOSIDASE; SALMONELLOSIS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PROMOTER REGION; SALMONELLA TYPHIMURIUM; ANIMAL; FEMALE; GENETICS; IMMUNE SYSTEM; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; EUKARYOTA; MUS; PROKARYOTA; SALMONELLA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BASE SEQUENCE; BETA-GALACTOSIDASE; CYTOMEGALOVIRUS; FEMALE; IMMUNE SYSTEM; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; SALMONELLA VACCINES; VACCINES, DNA;

EID: 67649467482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006062     Document Type: Article

References (28)

1. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, et al. (1997) Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91: 765-775.
2. Schoen C, Stritzker J, Goebel W, Pilgrim S (2004) Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 294: 319-335.
3. Xu F, Ulmer JB (2003) Attenuated Salmonella and Shigella as carriers for DNA vaccines. J Drug Target 11: 481-488.
4. Loessner H, Weiss S (2004) Bacteria-mediated DNA transfer in gene therapy and vaccination. Expert Opin Biol Ther 4: 157-168.
5. Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA (2003) Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr Opin Mol Ther 5: 10-19.
6. Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, et al. (1999) Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17 Suppl 2: S22-27.
7. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP (1998) Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92: 3172-3176.
8. Flo J, Tisminetzky S, Baralle F (2001) Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 19: 1772-1782.
9. Darji A, zur Lage S, Garbe AI, Chakraborty T, Weiss S (2000) Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 27: 341-349.
10. Goussard S, Grillot-Courvalin C, Courvalin P (2003) Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria. J Mol Microbiol Biotechnol 6: 211-218.
11. Twigg AJ, Sherratt D (1980) Trans-complementable copy-number mutants of plasmid ColE1. Nature 283: 216-218.
12. Fairweather NF, Chatfield SN, Makoff AJ, Strugnell RA, Bester J, et al. (1990) Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect Immun 58: 1323-1326.
13. Yang J, Hwang JS, Camakaris H, Irawaty W, Ishihama A, et al. (2004) Mode of action of the TyrR protein: repression and activation of the tyrP promoter of Escherichia coli. Mol Microbiol 52: 243-256.
14. Hudson GS, Davidson BE (1984) Nucleotide sequence and transcription of the phenylalanine and tyrosine operons of Escherichia coli K12. J Mol Biol 180: 1023-1051.
15. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.
16. Gahan ME, Webster DE, Wesselingh SL, Strugnell RA (2007) Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine 25: 1476-1483.
17. Keilty S, Rosenberg M (1987) Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J Biol Chem 262: 6389-6395.
18. Kumar A, Malloch RA, Fujita N, Smillie DA, Ishihama A, et al. (1993) The minus 35-recognition region of Escherichia coli sigma 70 is inessential for initiation of transcription at an "extended minus 10" promoter. J Mol Biol 232: 406-418.
19. Yanofsky C, Platt T, Crawford IP, Nichols BP, Christie GE, et al. (1981) The complete nucleotide sequence of the tryptophan operon of Escherichia coli. Nucleic Acids Res 9: 6647-6668.
20. Weiner DB (2008) DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine 26: 5073-5074.
21. Dunstan SJ, Simmons CP, Strugnell RA (1999) Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium. Infect Immun 67: 5133-5141.
22. Marshall DG, Haque A, Fowler R, Del Guidice G, Dorman CJ, et al. (2000) Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains. Vaccine 18: 1298-1306.
23. Mulligan ME, Hawley DK, Entriken R, McClure WR (1984) Escherichia coli promoter sequences predict in vitro RNA polymerase selectivity. Nucleic Acids Res 12: 789-800.
24. Lisser S, Margalit H (1993) Compilation of E. coli mRNA promoter sequences. Nucleic Acids Res 21: 1507-1516.
25. Lewin A, Mayer M, Chusainow J, Jacob D, Appel B (2005) Viral promoters can initiate expression of toxin genes introduced into Escherichia coli. BMC Biotechnol 5: 19.
26. Pasetti MF, Anderson RJ, Noriega FR, Levine MM, Sztein MB (1999) Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin Immunol 92: 76-89.
27. Anderson RJ, Pasetti MF, Sztein MB, Levine MM, Noriega FR (2000) DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin. Vaccine 18: 2193-2202.
28. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, et al. (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41: 521-530.